Marshall Wace’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-95,339
| Closed | -$1.11M | – | 2773 |
|
|
2024
Q4 | $1.11M | Buy |
+95,339
| New | +$1.11M | ﹤0.01% | 1568 |
|
|
2024
Q2 | – | Sell |
-335,408
| Closed | -$9.23M | – | 2566 |
|
|
2024
Q1 | $9.23M | Sell |
335,408
-555,090
| -62% | -$15.3M | 0.01% | 678 |
|
|
2023
Q4 | $27.2M | Buy |
+890,498
| New | +$27.2M | 0.05% | 333 |
|
|
2023
Q1 | – | Sell |
-389,074
| Closed | -$13.6M | – | 2455 |
|
|
2022
Q4 | $13.6M | Buy |
389,074
+381,674
| +5,158% | +$13.3M | 0.03% | 558 |
|
|
2022
Q3 | $414K | Sell |
7,400
-2,724
| -27% | -$152K | ﹤0.01% | 2107 |
|
|
2022
Q2 | $524K | Sell |
10,124
-96,192
| -90% | -$4.98M | ﹤0.01% | 2130 |
|
|
2022
Q1 | $7.73M | Buy |
+106,316
| New | +$7.73M | 0.01% | 989 |
|
|
2021
Q3 | – | Sell |
-74,744
| Closed | -$12.1M | – | 2690 |
|
|
2021
Q2 | $12.1M | Buy |
74,744
+59,835
| +401% | +$9.69M | 0.05% | 344 |
|
|
2021
Q1 | $1.2M | Buy |
14,909
+1,443
| +11% | +$116K | 0.01% | 1328 |
|
|
2020
Q4 | $733K | Buy |
+13,466
| New | +$733K | ﹤0.01% | 1202 |
|
|
2016
Q3 | – | Sell |
-11,408
| Closed | -$244K | – | 1067 |
|
|
2016
Q2 | $244K | Buy |
+11,408
| New | +$244K | ﹤0.01% | 909 |
|